Beginning February 26, 2018, testing for Trichomonas vaginalis using molecular technology on the BD Viper XTR will be available upon request at LifeLabs Medical Laboratories. This test will offer a h...

​**Update on Turn Around Times** Recent technical issues have been resolved for Anti-Nuclear Antibody(ANA) testing. Service of published Turn Around Times has resumed. Thank you for your patienc...

​LifeLabs was recently notified of a reagent product recall regarding Amoxicilloyl and Ampicilloyl Allergens.  This recall was voluntarily initiated by the manufacturer. This letter is to inform yo...

**Update on Turn Around Times** Due to vendor supply issues, we are currently experiencing a delay in TAT for Amoxicilloyl (c6) and Ampicilloyl (c5) testing. No other source of reagents or other t...

LifeLabs Ontario Medical Director Update Staff Changes in Anatomic Pathology Dr. Terry Colgan and Dr. Mona Kamel have joined the Medical-Scientific staff at LifeLabs. Dr. Colgan will be the Discipli...

​On December 11th, 2017 LifeLabs will introduce a new methodology for carcinoembrionic antigen (CEA) testing, based on the Roche Cobas system. Please note that patients whose samples are sent to ho...

​LifeLabs is introducing new assay methods for therapeutic drug monitoring (TDM) tests, and for ASOT (antistreptolysin O antibodies / titer), ceruloplasmin and haptoglobin testing.  For some tests ...